Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.

Takahito Hara(Takeda (Japan)), Masaomi Miyamoto(Io Therapeutics (United States)), Jun‐ichi Miyazaki(The University of Osaka), Naoyuki Kanzaki, Masuo Yamaoka, Masami Kusaka(Takeda (Japan)), Hideo Araki(Hiroshima University)
PubMed
January 1, 2003
Cited by 427

Related Papers

Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent
|Biochemical and Biophysical Research Communications|1991|323
Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470)
|British Journal of Cancer|1994|243
Cell competition with normal epithelial cells promotes apical extrusion of transformed cells through metabolic changes
|Nature Cell Biology|2017|234
Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response
|Proceedings of the National Academy of Sciences|2018|172
Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice
|Arthritis & Rheumatism|2003|148